These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 27156108)

  • 41. [Hemolytic anemias in adults].
    Müller A; Zimmermann R; Krause SW
    Dtsch Med Wochenschr; 2011 Nov; 136(45):2308-12. PubMed ID: 22048936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Activation of Complement and Its Role in the Pathogenesis of Thromboembolism.
    Boyce S; Eren E; Lwaleed BA; Kazmi RS
    Semin Thromb Hemost; 2015 Sep; 41(6):665-72. PubMed ID: 26305235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
    Song D; Yu XJ; Wang FM; Xu BN; He YD; Chen Q; Wang SX; Yu F; Song WC; Zhao MH
    Am J Reprod Immunol; 2015 Oct; 74(4):345-56. PubMed ID: 26011580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The significance of complement in immunohematology.
    Garratty G
    Crit Rev Clin Lab Sci; 1984; 20(1):25-56. PubMed ID: 6373144
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pathogenesis of erythrocyte destruction in autoimmune hemolytic anemia].
    Yatomi Y
    Nihon Rinsho; 1996 Sep; 54(9):2397-401. PubMed ID: 8890568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paroxysmal nocturnal hemoglobinuria and the age of therapeutic complement inhibition.
    Varela JC; Brodsky RA
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1113-24. PubMed ID: 24168416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transfusion therapy in autoimmune hemolytic anemia.
    Jefferies LC
    Hematol Oncol Clin North Am; 1994 Dec; 8(6):1087-104. PubMed ID: 7860438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of complement-mediated immune hemolysis by a small molecule compound.
    Mqadmi A; Zheng X; Song J; Abramowitz S; Giclas P; Yazdanbakhsh K
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1465-71. PubMed ID: 15555593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombosis in heritable hemolytic disorders.
    Barker JE; Wandersee NJ
    Curr Opin Hematol; 1999 Mar; 6(2):71-5. PubMed ID: 10088635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thrombotic Complications in Patients with Immune-Mediated Hemolysis.
    Capecchi M; Ciavarella A; Artoni A; Abbattista M; Martinelli I
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33919638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pregnancy-related thrombotic microangiopathies: Clues from complement biology.
    Fakhouri F
    Transfus Apher Sci; 2016 Apr; 54(2):199-202. PubMed ID: 27158062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms of Complement-Mediated Damage in Hematological Disorders.
    Taylor RP; Lindorfer MA
    Semin Hematol; 2018 Jul; 55(3):118-123. PubMed ID: 30032747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune-mediated hemolytic anemia.
    Rosse WF; Hillmen P; Schreiber AD
    Hematology Am Soc Hematol Educ Program; 2004; ():48-62. PubMed ID: 15561676
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical roundtable monograph: Paroxysmal nocturnal hemoglobinuria: a case-based discussion.
    Szer J; Hill A; Weitz IC
    Clin Adv Hematol Oncol; 2012 Nov; 10(11 Suppl 21):1-16. PubMed ID: 23271156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Anesthetic management of a patient with paroxysmal nocturnal hemoglobinuria].
    Hano K
    Masui; 2012 Jul; 61(7):761-4. PubMed ID: 22860310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches.
    Riedl M; Fakhouri F; Le Quintrec M; Noone DG; Jungraithmayr TC; Fremeaux-Bacchi V; Licht C
    Semin Thromb Hemost; 2014 Jun; 40(4):444-64. PubMed ID: 24911558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Laboratory tests for disorders of complement and complement regulatory proteins.
    Shih AR; Murali MR
    Am J Hematol; 2015 Dec; 90(12):1180-6. PubMed ID: 26437749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions.
    Karpman D; Ståhl AL; Arvidsson I; Johansson K; Loos S; Tati R; Békássy Z; Kristoffersson AC; Mossberg M; Kahn R
    Adv Exp Med Biol; 2015; 865():19-42. PubMed ID: 26306441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complement in Hemolysis- and Thrombosis- Related Diseases.
    Luo S; Hu D; Wang M; Zipfel PF; Hu Y
    Front Immunol; 2020; 11():1212. PubMed ID: 32754149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.